Preceptis Medical Inc., a U.S.-based pediatric surgical technologies developer, has reached the initial closing of its series B financing round led by a group of unnamed Chinese private investors. No financial details were disclosed in a company announcement. With the investment, Preceptis plans to accelerate its global expansion to China with the assistance from its new Chinese partners, according to a company announcement. Founded in 2011, Preceptis develops Hummingbird Tympanostomy Tube System technology that enables a conscious sedation alternative to …
US Healthcare Firm Preceptis Raises New Funding Round From Chinese Investors, Eyes China Expansion appeared first on China Money Network.